These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bioethical catch-22: the moratorium on federal funding of fetal tissue transplantation research and the NIH revitalization amendments. Maroney HM J Contemp Health Law Policy; 1993; 9():485-519. PubMed ID: 10126947 [TBL] [Abstract][Full Text] [Related]
4. Congress, health care, and congressional caucuses: an examination of the Diabetes Caucus. Burgin E J Health Polit Policy Law; 2003 Oct; 28(5):789-820. PubMed ID: 14604213 [TBL] [Abstract][Full Text] [Related]
5. Proposed US Government budget cuts would 'devastate' cancer research. Furlow B Lancet Oncol; 2017 May; 18(5):577. PubMed ID: 28343979 [No Abstract] [Full Text] [Related]
6. A diabetes drama for President Obama. Dansinger M Medscape J Med; 2009; 11(1):32. PubMed ID: 19295953 [No Abstract] [Full Text] [Related]
7. Cancer groundshot: going global before going to the moon. Gyawali B; Sullivan R; Booth CM Lancet Oncol; 2018 Mar; 19(3):288-290. PubMed ID: 29508746 [No Abstract] [Full Text] [Related]
8. Politics and health: recent debate in Congress questions some government grants. Bruckbauer S J Natl Cancer Inst; 2004 Feb; 96(3):169-70. PubMed ID: 14759979 [No Abstract] [Full Text] [Related]
9. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]. Flórez H Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072 [TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE; Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451 [TBL] [Abstract][Full Text] [Related]
11. Researchers fear the future as Congress settles 2003 budget. Hoag H Nature; 2003 Feb; 421(6925):774. PubMed ID: 12594466 [No Abstract] [Full Text] [Related]
13. AIDS funding bills now before House-Senate conferees. AIDS Policy Law; 1997 Oct; 12(18):14-5. PubMed ID: 11364725 [TBL] [Abstract][Full Text] [Related]
14. An eye on the federal budget. Jennings CP Nurs Spectr (Wash D C); 1998 Mar; 8(5):10. PubMed ID: 10542693 [No Abstract] [Full Text] [Related]
15. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Eddy DM; Schlessinger L; Kahn R Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469 [TBL] [Abstract][Full Text] [Related]
16. Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Li R; Qu S; Zhang P; Chattopadhyay S; Gregg EW; Albright A; Hopkins D; Pronk NP Ann Intern Med; 2015 Sep; 163(6):452-60. PubMed ID: 26167962 [TBL] [Abstract][Full Text] [Related]
17. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018. Wouters OJ JAMA Intern Med; 2020 May; 180(5):688-697. PubMed ID: 32125357 [TBL] [Abstract][Full Text] [Related]
18. Surprise US election results may boost biotech. Fox JL Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655 [No Abstract] [Full Text] [Related]